Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,747,845
-
Total 13F shares
-
740,370
-
Share change
-
-648,456
-
Total reported value
-
$1,080,988
-
Put/Call ratio
-
333%
-
Price per share
-
$1.46
-
Number of holders
-
25
-
Value change
-
-$948,245
-
Number of buys
-
4
-
Number of sells
-
9
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q1 2025
As of 31 Mar 2025,
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
740,370 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, SeaCrest Wealth Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock, Inc., and CITADEL ADVISORS LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.